Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.53 million shares were traded. NMRA stock price reached its highest trading level at $1.845 during the session, while it also had its lowest trading level at $1.715.
Ratios:
Our goal is to gain a better understanding of NMRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.54 and its Current Ratio is at 10.54. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
On April 02, 2025, BofA Securities Downgraded its rating to Underperform which previously was Buy but kept the price unchanged to $1.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 288262848 and an Enterprise Value of 90635864.
Stock Price History:
The Beta on a monthly basis for NMRA is 2.94, which has changed by -0.87940377 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $17.19, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 3.42%, while the 200-Day Moving Average is calculated to be -7.86%.
Shares Statistics:
The stock has traded on average 1.09M shares per day over the past 3-months and 522270 shares per day over the last 10 days, according to various share statistics. A total of 161.95M shares are outstanding, with a floating share count of 54.24M. Insiders hold about 66.51% of the company’s shares, while institutions hold 22.97% stake in the company. Shares short for NMRA as of 1757894400 were 6417308 with a Short Ratio of 5.90, compared to 1755216000 on 5276271. Therefore, it implies a Short% of Shares Outstanding of 6417308 and a Short% of Float of 10.93.
Earnings Estimates
Currently, 6.0 analysts are dedicated to thoroughly evaluating and rating the performance of Neumora Therapeutics Inc (NMRA) in the stock market.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.28 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.32 and -$1.54 for the fiscal current year, implying an average EPS of -$1.42. EPS for the following year is -$1.01, with 6.0 analysts recommending between -$0.58 and -$1.62.
